Drug prices are too high.


CNN: Sens. Grassley, Wyden reach bipartisan deal to lower drug prices

The Senate Finance Committee Tuesday rolled out its long-awaited bipartisan plan aimed at lowering prescription drug prices.

Committee Chairman Sen. Chuck Grassley, Republican of Iowa, and Ranking Member Sen. Ron Wyden, Democrat of Oregon, are the latest congressional duo to address the problem that’s a top priority for many Americans, as well as President Donald Trump.

read more

Gallup: Big Pharma Sinks to the Bottom of U.S. Industry Rankings

The pharmaceutical industry is now the most poorly regarded industry in Americans’ eyes, ranking last on a list of 25 industries that Gallup tests annually. Americans are more than twice as likely to rate the pharmaceutical industry negatively (58%) as positively (27%), giving it a net-positive score of -31. The restaurant industry is rated most positively.

read more

Vox: The new bipartisan Senate bill aimed at making Big Pharma lower drug prices, explained

While many pharmaceutical companies benefit from federal funding for research, this doesn’t necessarily translate to lower prices for patients who ultimately buy the drugs that are developed. In other words, the government is effectively subsidizing companies’ ability to develop drugs and then charge exorbitant prices for them.

Sens. Chris Van Hollen (D-MD) and Rick Scott (R-FL) want to change that.

read more